As of 2024-09-12, the Relative Valuation of Coherus BioSciences Inc (CHRS) is (7.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.33 USD, the upside of Coherus BioSciences Inc based on Relative Valuation is -634.0%.
The range of the Relative Valuation is (6.44) - (6.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.3x - 38.4x | 31.5x |
| Forward P/E multiples | 21.5x - 27.0x | 24.4x |
| Fair Price | (6.44) - (6.87) | (7.10) |
| Upside | -584.1% - -616.3% | -634.0% |
| Date | P/E |
| 2024-09-11 | -5.23 |
| 2024-09-10 | -5.35 |
| 2024-09-09 | -5.15 |
| 2024-09-06 | -4.88 |
| 2024-09-05 | -5.19 |
| 2024-09-04 | -5.15 |
| 2024-09-03 | -5.35 |
| 2024-08-30 | -5.47 |
| 2024-08-29 | -5.58 |
| 2024-08-28 | -5.35 |
| 2024-08-27 | -5.47 |
| 2024-08-26 | -5.70 |
| 2024-08-23 | -5.47 |
| 2024-08-22 | -5.19 |
| 2024-08-21 | -5.27 |
| 2024-08-20 | -4.92 |
| 2024-08-19 | -4.97 |
| 2024-08-16 | -4.95 |
| 2024-08-15 | -6.09 |
| 2024-08-14 | -5.39 |
| 2024-08-13 | -5.66 |
| 2024-08-12 | -5.74 |
| 2024-08-09 | -5.62 |
| 2024-08-08 | -5.07 |
| 2024-08-07 | -4.88 |
| 2024-08-06 | -5.23 |
| 2024-08-05 | -5.19 |
| 2024-08-02 | -5.31 |
| 2024-08-01 | -5.62 |
| 2024-07-31 | -6.06 |
| 2024-07-30 | -6.06 |
| 2024-07-29 | -6.45 |
| 2024-07-26 | -6.76 |
| 2024-07-25 | -6.21 |
| 2024-07-24 | -5.94 |
| 2024-07-23 | -6.53 |
| 2024-07-22 | -6.68 |
| 2024-07-19 | -6.45 |
| 2024-07-18 | -6.17 |
| 2024-07-17 | -6.84 |
| 2024-07-16 | -7.08 |
| 2024-07-15 | -6.49 |
| 2024-07-12 | -6.53 |
| 2024-07-11 | -6.33 |
| 2024-07-10 | -5.62 |
| 2024-07-09 | -5.70 |
| 2024-07-08 | -4.99 |
| 2024-07-05 | -5.23 |
| 2024-07-03 | -5.47 |
| 2024-07-02 | -5.47 |